US2003139375A1PendingUtilityA1
Chlamydia oligosaccharides
Priority: Feb 19, 1999Filed: Nov 5, 2002Published: Jul 24, 2003
Est. expiryFeb 19, 2019(expired)· nominal 20-yr term from priority
A61K 31/702C07H 3/06A61K 31/715
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Oligosaccharides specific for Chlamydia mediate attachment of the organism to host cells.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A composition comprising a carbohydrate, or a derivative thereof, wherein said carbohydrate comprises at least five mannose residues; wherein said carbohydrate comprises a branched trimannosyl core, wherein a mannose residue optionally is bonded thereto; wherein said carbohydrate comprises at least three branches and each branch terminates in a mannose residue; and wherein said carbohydrate or derivative is present in an amount which inhibits binding of chlamydia to a mammalian cell, and a biologically acceptable carrier, diluent or excipient.
2 . The composition of claim 1 , wherein said carbohydrate comprises at least six mannose residues.
3 . The composition of claim 2 , wherein said carbohydrate comprises at least seven mannose residues.
4 . The composition of claim 3 , wherein said carbohydrate comprises at least eight residues.
5 . The composition of claim 1 , wherein trimannosyl core is linked to chitobiose.
6 . The composition of claim 5 , wherein said chitobiose is linked to an asparagine.
7 . The composition of claim 1 , wherein said carbohydrate has at least three branches.
8 . The composition of claim 1 , wherein said carbohydrate has at least four branches.
9 . A method of inhibiting binding of chlamydia to a mammalian cell comprising exposing said chlamydia, to a carbohydrate, or a derivative thereof, wherein said carbohydrate comprises at least five mannose residues; wherein said carbohydrate comprises a branched trimannosyl core, wherein a mannose residue optionally is bonded thereto; wherein said carbohydrate comprises at least three branches and each branch terminates in a mannose residue; and wherein said carbohydrate or derivative is present in an amount which inhibits binding of chlamydia to a mammalian cell.
10 . An isolated Chlamydia carbohydrate comprising at least five mannose residues; wherein said carbohydrate comprises a branched trimannosyl core, wherein a mannose residue optionally is bonded thereto; and wherein said carbohydrate comprises at least three branches and each branch terminates in a mannose residue.
11 . A multivalent carbohydratecomprising two or more carbohydrates linked to a carrier, wherein said carbohydrate comprises at least five mannose residues; wherein said carbohydrate comprises a branched trimannosyl core, wherein a mannose residue optionally is bonded thereto; and wherein said carbohydrate comprises at least three branches and each branch terminates in a mannose residue.Join the waitlist — get patent alerts
Track US2003139375A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.